Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | CCR8 | P51685 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484776 | 0.94 | KDM4E (0.37) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL16484750 | 0.92 | KDM4E (0.35) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17012369 | 0.92 | KDM4E (0.39) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17012388 | 0.92 | TGFBR1 (0.37) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17012387 | 0.91 | MAPK1 (0.39) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17012327 | 0.91 | PRKDC (0.36) | KDM4EMAPK1TP53SMN1; SMN2METAP1 | |
| SCHEMBL17012319 | 0.91 | PRKDC (0.37) | MAPK1HSD17B10TSHRTGFBR1GRM5 | |
| SCHEMBL17012378 | 0.90 | CCR1 (0.35) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17012324 | 0.89 | TGFBR1 (0.36) | KDM4EMAPK1CCR1CCR5CCR8 | |
| SCHEMBL17132508 | 0.88 | TGFBR1 (0.38) | MAPK1HSD17B10TSHRTGFBR1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2907803-B1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | TORAY INDUSTRIES (JP) | 2021-08-18 | — | — | EP | disclosed |
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| EP-2907803-A1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | Toray Industries, Inc. (JP) | 2015-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | FMNL1, AFF2, LEF1 | KDM4E 502/4885MAPK1 3437/4885CCR1 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.